ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,364Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 2094

$770K Total Retail Price of All Prescriptions

Rank: 196 out of 2094

404 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 8,083 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 453 398 1 2
SIMVASTATIN 350 301 2 1
FUROSEMIDE 270 249 3 6
METOPROLOL SUCCINATE 259 232 4 9
ZOLPIDEM TARTRATE 234 210 5 14
AMLODIPINE BESYLATE-BENAZEPRIL 210 182 6 58
METFORMIN HCL 182 137 7 8
MELOXICAM 178 147 8 49
LOSARTAN POTASSIUM 172 129 9 17
LANTUS SOLOSTAR 165 147 10 76
DIOVAN 165 144 10 13
GLIMEPIRIDE 165 150 10 31
OMEPRAZOLE 151 140 13 4
ATORVASTATIN CALCIUM 149 104 14 5
CLOPIDOGREL 149 135 14 22
PROAIR HFA 144 118 16 45
NEXIUM 132 103 17 16
OXYCODONE-ACETAMINOPHEN 125 120 S2 18 40
ENDOCET 114 105 S2 19 88
PLAVIX 114 109 19 38
SPIRIVA 101 77 21 60
ADVAIR DISKUS 92 75 22 36
PANTOPRAZOLE SODIUM 91 81 23 37
LEVOTHYROXINE SODIUM 90 87 24 3
IBUPROFEN 89 63 25 73
VENTOLIN HFA 87 74 26 132
DILTIAZEM 24HR CD 86 82 27 110
CARVEDILOL 86 75 27 19
PEN NEEDLE 82 66 29 136
HYDROCODONE-ACETAMINOPHEN 79 71 S3 30 42
PRAVASTATIN SODIUM 75 73 31 18
NOVOLOG FLEXPEN 75 60 31 142
TRAMADOL HCL 74 54 33 33
POLYETHYLENE GLYCOL 3350 70 64 34 75
AZITHROMYCIN 69 54 35 27
HYDROCORTISONE VALERATE 68 59 36 268
DIOVAN HCT 68 55 36 28
TAMSULOSIN HCL 66 62 38 29
GLIPIZIDE XL 65 56 39 122
OXYBUTYNIN CHLORIDE ER 65 61 39 138
DIGOXIN 64 58 41 51
HUMALOG 62 59 42 164
CIPROFLOXACIN HCL 61 49 43 81
SPIRONOLACTONE 61 50 43 93
JANUVIA 59 56 45 35
ISOSORBIDE MONONITRATE ER 59 58 45 57
BENICAR 58 53 47 108
POTASSIUM CHLORIDE 56 56 48 24
HYDROCHLOROTHIAZIDE 56 50 48 12
NAPROXEN 54 54 50 84
FEXOFENADINE HCL 53 44 51 191
METOCLOPRAMIDE HCL 52 52 52 141
LACTULOSE 51 48 53 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.